Skip to main content
Log in

Topical methyl aminolevulinate: profile report

  • Drugs and Profile Reports
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 1 The use of trade names is for product identification purposes only and does not imply endorsement.

References

  1. Siddiqui MAA, Perry CM, Scott LJ. Topical methyl aminolevulinate. Am J Clin Dermatol 2004; 5(2): 127–37

    Article  PubMed  Google Scholar 

  2. Braathen LR. Topical methyl aminolevulinate: a viewpoint. Am J Clin Dermatol 2004; 5(2): 138

    Article  Google Scholar 

  3. Rhodes LE. Topical methyl aminolevulinate: a viewpoint. Am J Clin Dermatol 2004; 5(2): 139–40

    Article  Google Scholar 

  4. Ormrod D, Jarvis B. Topical aminolevulinic acid HC1 photodynamic therapy. Am J Clin Dermatol 2000; 1(2): 133–41

    Article  PubMed  CAS  Google Scholar 

  5. Gaullier JM, Berg K, Peng Q, et al. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res 1997; 57(8): 1481–6

    PubMed  CAS  Google Scholar 

  6. Braathen L, Paredes B, Frolich K, et al. A dose finding study of photodynamic therapy (PDT) with Metvix in actinic keratosis (AK) [abstract no. W24-03]. J Eur Acad Dermatol Venereol 2000; 14 Suppl. 1: 38

    Google Scholar 

  7. Basset-Seguin N, Bachmann Y, Pavel S, et al. A dose finding study of photodynamic therapy with Metvix in patients with basal cell carcinoma [abstract]. J Eur Acad Dermatol Venereol 2000; 14 Suppl. 1: 39

    Google Scholar 

  8. Pariser DM, Lowe NJ, Stewart DM, et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 2003 Feb; 48 Suppl. 2: 227–32

    Article  PubMed  Google Scholar 

  9. Szeimies RM, Karrer S, Radakovic-Fijan S, et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cry-otherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 2002 Aug; 47(2): 258–62

    Article  PubMed  CAS  Google Scholar 

  10. Freeman M, Vinciullo C, Francis D, et al. A comparison of photo-dynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatol Treat 2003; 14(2): 99–106

    Article  CAS  Google Scholar 

  11. Foley P, Freeman M, Siller G, et al. A phase III randomized study comparing photodynamic therapy (PDT) using methyl aminolevulinate or placebo cream in nodular basal cell carcinoma (nBCC) [abstract no. P9.14]. 12th Annual Congress of the European Academay of Dermatology and Venereology; 2003 Oct 15–18; Barcelona

  12. Tope WD, Menter A, El-Azhary RA, et al. Comparison of topical methylaminolevulinate photodynamic therapy versus placebo photodynamic therapy in nodular basal cell carcinoma [abstract no. P477]. J Am Acad Dermatol 2004; 50(3 Suppl. ): P123

    Article  Google Scholar 

  13. Basset-Seguin N, Ibbotson S, Emtestam L, et al. Photodynamic therapy using Metvix is as efficacious as cryotherapy in BCC, with better cosmetic results [poster]. 10th Congress of the European Academy of Dermatology and Venereology; 2001 Oct 10–14; Munich

  14. Rhodes LE, de Rie M, Enström Y, et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 2004; 140(1): 17–23

    Article  PubMed  CAS  Google Scholar 

  15. Horn M, Wolf P, Wulf HC, et al. Topical methyl aminolevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 2003; 149(6): 1242–9

    Article  PubMed  CAS  Google Scholar 

  16. Viniciullo C, Elliott T, Gebauer K, et al. Photodynamic therapy using methyl aminolevulinate in patients with basal cell carcinoma [abstract no. P478]. J Am Acad Dermatol 2004; 50(3 Suppl. ): P124

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Topical methyl aminolevulinate: profile report. Drugs Ther. Perspect 20, 6–8 (2004). https://doi.org/10.2165/00042310-200420110-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200420110-00002

Navigation